Media Summary: Things we have learned in the RPE65 Gene Therapy Trial. Q & A with Dr. Bennett and her team as well as a young patient who participated in the trial. Moving from basic research to clinical trial development in the setting of a basic research lab.
Chapter 5 Arvo 2014 Closing - Detailed Analysis & Overview
Things we have learned in the RPE65 Gene Therapy Trial. Q & A with Dr. Bennett and her team as well as a young patient who participated in the trial. Moving from basic research to clinical trial development in the setting of a basic research lab. Funding in Gene Therapy: A short history and a shifting landscape. Provided to YouTube by The Orchard Enterprises Subscribe for more: ▻ Follow us on Twitter: ▻ Like us at Facebook: ...
Laura Periman, MD shares a Harvard research poster and the effect of increased substance P limiting regulatory T cell function. 2014 ARVO Annual Meeting Opening Keynote video Scientists have developed working therapies for patients along the way, including the gene therapy Luxturna, which was ...
